Literature DB >> 28754810

Infective endocarditis in adults with congenital heart disease remains a lethal disease.

Oktay Tutarel1,2, Rafael Alonso-Gonzalez1, Claudia Montanaro1, Renee Schiff1, Aitor Uribarri1, Aleksander Kempny1, Martin R Grübler1,3, Anselm Uebing1, Lorna Swan1, Gerhard-Paul Diller1,4,5, Konstantinos Dimopoulos1,4, Michael A Gatzoulis1,4.   

Abstract

OBJECTIVE: Infective endocarditis (IE) is associated with significant morbidity and mortality. Patients with adult congenital heart disease (ACHD) have an increased risk of developing IE. The aim of this study is to describe the incidence, predictors of outcome and mortality associated with IE in ACHD in a contemporary cohort.
METHODS: All episodes of IE in adults with congenital heart disease referred to our tertiary centre between 1999 and 2013 were included in the study. Patients were identified from the hospital database. The diagnosis of endocarditis was established according to the modified Duke criteria. The primary endpoint of the study was endocarditis-associated mortality.
RESULTS: There were 164 episodes of IE in 144 patients (male 102, 70.8%). Mean age at presentation was 32.3±22.7 years. Out of these, 43% had a simple, 23% a moderate and 32% a complex lesion. It was at least the second bout of IE in 37 episodes (23%). A predisposing event could be identified in only 26.2% of episodes. Surgical intervention during the same admission was performed in 61 episodes (37.2%). During a median follow-up of 6.7 years (IQR 2.9-11.4), 28 (19.4%) patients died. Out of these, 10 deaths were related to IE (IE mortality 6.9%). On unvariate regression analysis, the development of an abscess (OR: 7.23; 95% CI 1.81 to 28.94, p<0.01) and age (OR: 1.05; 95% CI 1.01 to 1.10, p=0.03) were the only predictors of IE-associated mortality. There was no increase in IE cases at our centre during the period of the study.
CONCLUSIONS: IE-associated morbidity and mortality in a contemporary cohort of ACHD patients is still high in the current era. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adult congenital heart disease; infective endocarditis

Mesh:

Year:  2017        PMID: 28754810     DOI: 10.1136/heartjnl-2017-311650

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

Review 2.  Infective Endocarditis: Update on Epidemiology, Outcomes, and Management.

Authors:  Logan L Vincent; Catherine M Otto
Journal:  Curr Cardiol Rep       Date:  2018-08-16       Impact factor: 2.931

Review 3.  Anesthetic Management in Adults with Congenital Heart Disease.

Authors:  Jon S Andrews; Nazish K Hashmi
Journal:  Curr Cardiol Rep       Date:  2022-01-26       Impact factor: 2.931

4.  Awareness of oral health in adults with congenital heart disease.

Authors:  Stefan Hollatz; Annette Wacker-Gussmann; Saskia Wilberg; Matthias Folwaczny; Rhoia Neidenbach; Harald Kaemmerer; Peter Ewert; Renate Oberhoffer
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 5.  Adult congenital heart disease and the COVID-19 pandemic.

Authors:  Robert M Radke; Tim Frenzel; Helmut Baumgartner; Gerhard-Paul Diller
Journal:  Heart       Date:  2020-06-10       Impact factor: 5.994

6.  Stress related disorders and subsequent risk of life threatening infections: population based sibling controlled cohort study.

Authors:  Huan Song; Katja Fall; Fang Fang; Helga Erlendsdóttir; Donghao Lu; David Mataix-Cols; Lorena Fernández de la Cruz; Brian M D'Onofrio; Paul Lichtenstein; Magnús Gottfreðsson; Catarina Almqvist; Unnur A Valdimarsdóttir
Journal:  BMJ       Date:  2019-10-23

7.  Predictors of Complications Secondary to Infective Endocarditis and Their Associated Outcomes: A Large Cohort Study from the National Emergency Database (2016-2018).

Authors:  Tanveer Mir; Mohammed Uddin; Waqas T Qureshi; Neelambuj Regmi; Imad M Tleyjeh; Ghulam Saydain
Journal:  Infect Dis Ther       Date:  2021-11-24

8.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

Review 9.  Complex adult congenital heart disease on cross-sectional imaging: an introductory overview.

Authors:  Mahdi Saleh; David Gendy; Inga Voges; Eva Nyktari; Monika Arzanauskaite
Journal:  Insights Imaging       Date:  2022-04-25

10.  MEF2C loss-of-function mutation contributes to congenital heart defects.

Authors:  Xiao-Hui Qiao; Fei Wang; Xian-Ling Zhang; Ri-Tai Huang; Song Xue; Juan Wang; Xing-Biao Qiu; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2017-09-08       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.